Year in Review: Top 20 therapeutic groups by gross spend

Rank Therapeutic Group Main Indication 2015/
16
2016/
17
2017/
18
2018/
19
2019/
20
      $m $m $m $m $m
1 Immunosuppressants Autoimmune conditions, arthritis, transplant and biologics for cancer $162.4  $192.1   $216.9 $247.7 $279.9
2 Antivirals Hepatitis C $22.1  $124.8 $84.4 $144.0 $135.1
3 Vaccinations Vaccine preventable diseases $92.4 $97.6 $137.1 $125.0 $124.0
4 Chemotherapeutic Agents Cancer $75.1  $83.3 $86.1 $93.5 $103.6
5 Antithrombotic Agents Stopping blood clots $63.5 $53.0 $56.0 $66.1 $75.9
6 Diabetes Diabetes  $50.6 $53.9 $57.5 $63.4 $75.8
Inhaled long-acting beta-adrenoceptor agonists Respiratory conditions $55.4 $53.0 $55.8 $58.4 $63.4
8 Antifibrinolytics, haemostatics and local sclerosants Haemophilia $29.6  $29.2 $28.2 $33.0 $50.3
9 Endocrine therapy HRT $28.2 $32.0 $35.8 $38.1 $41.2
10 Antipsychotics Mental health $33.3 $35.7 $37.0 $33.1 $35.6
11  Multiple sclerosis treatments Multiple Sclerosis  $20.2  $24.6 $28.5 $30.1 $33.3
12 Anticholinergic agents Respiratory conditions $18.4  $18.6 $22.7 $25.9 $28.8
13 Antiepilepsy drugs Epilepsy  $33.9 $35.5 $37.5 $36.4 $26.7
14 Diabetes management Blood glucose monitors and strips $19.1 $20.6 $22.2 $24.8 $25.1
15 Antiretrovirals HIV/AIDS $25.4 $27.8 $30.5 $24.5 $24.0
16 Oral supplements/complete diet (Nasogastric/gastrostomy tube feed) Special food $10.8 $13.0 $15.7 $16.7 $17.9
17 Analgesics Pain relief $20.4 $19.2 $18.1 $17.8 $17.4
18 Agents affecting the Renin-Angiotensin system Blood pressure, heart failure, kidney failure and effects of diabetes $12.3 $11.8 $12.3 $12.5 $15.5
19 Treatments for substances dependence Addiction  $15.2  $14.9 $16.3 $16.4 $13.7
20 Antibacterials Bacterial infections $14.2 $13.9 $13.5 $12.9 $13.3
    Totals $802.5  $954.5 $1,012.1 $1,120.3  $1,200.5

The data above excludes hospital purchases.

List order has been determined by top spend in the financial year 2019/20.

Gross spend is shown in millions NZD and is exclusive of GST, and prior to the application of rebates and discounts.